Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus

Diffuse alveolar hemorrhage (DAH) in lupus patients confers >50% mortality, and the cause is unknown. We undertook this study to examine the pathogenesis of DAH in C57BL/6 mice with pristane‐induced lupus, a model of human lupus‐associated DAH.

[1]  N. Starobinas,et al.  Mice Selected for Acute Inflammation Present Altered Immune Response during Pristane-Induced Arthritis Progression , 2018, BioMed research international.

[2]  J. Sancho,et al.  The Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus , 2018, International journal of molecular sciences.

[3]  J. Hodgin,et al.  Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction , 2018, Frontiers in Immunology.

[4]  M. Segal,et al.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM , 2016, Arthritis & rheumatology.

[5]  D. Dorward,et al.  Key mechanisms governing resolution of lung inflammation , 2016, Seminars in Immunopathology.

[6]  A. Gow,et al.  Role of NOS2 in pulmonary injury and repair in response to bleomycin. , 2016, Free radical biology & medicine.

[7]  John D Lambris,et al.  Complement inhibition decreases early fibrogenic events in the lung of septic baboons , 2015, Journal of cellular and molecular medicine.

[8]  L. Gregory,et al.  Pulmonary macrophages: key players in the innate defence of the airways , 2015, Thorax.

[9]  J. Renauld,et al.  IL‐1α induces CD11blow alveolar macrophage proliferation and maturation during granuloma formation , 2015, The Journal of pathology.

[10]  S. Maruyama,et al.  Pristane-Induced Granulocyte Recruitment Promotes Phenotypic Conversion of Macrophages and Protects against Diffuse Pulmonary Hemorrhage in Mac-1 Deficiency , 2014, The Journal of Immunology.

[11]  S. Groshong,et al.  Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVB/n mice. , 2014, Experimental and molecular pathology.

[12]  D. Fritzinger,et al.  Complement depletion with humanised cobra venom factor: Efficacy in preclinical models of vascular diseases , 2014, Thrombosis and Haemostasis.

[13]  C. Fell,et al.  Pulmonary Manifestations of Systemic Lupus Erythematosus , 2014, Seminars in Respiratory and Critical Care Medicine.

[14]  T. Hussell,et al.  Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.

[15]  Haoyang Zhuang,et al.  Toll‐like Receptor 7–Stimulated Tumor Necrosis Factor α Causes Bone Marrow Damage in Systemic Lupus Erythematosus , 2014, Arthritis & rheumatology.

[16]  J. Hodgin,et al.  An Essential Role of Caspase 1 in the Induction of Murine Lupus and Its Associated Vascular Damage , 2014, Arthritis & rheumatology.

[17]  H. Perlman,et al.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.

[18]  Bernard Malissen,et al.  Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF , 2013, The Journal of experimental medicine.

[19]  D. Kreisel,et al.  Processes of Sterile Inflammation , 2013, The Journal of Immunology.

[20]  U. Eriksson,et al.  Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease , 2013, Nature Protocols.

[21]  E. Szczęśniak,et al.  Exogenous lipoid pneumonia – a case report of a fire-eater , 2012, Polish journal of radiology.

[22]  S. Smale,et al.  Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways , 2012, Nature Immunology.

[23]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[24]  W. Janssen,et al.  Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[25]  S. Akira,et al.  Pathogenic role of B-cells in the development of diffuse alveolar hemorrhage induced by pristane , 2011, Laboratory Investigation.

[26]  V. Cottin,et al.  Alveolar hemorrhage in vasculitis: primary and secondary. , 2011, Seminars in respiratory and critical care medicine.

[27]  M. Martínez-Martínez,et al.  Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus , 2011, Lupus.

[28]  S. Akira,et al.  IL-1α Modulates Neutrophil Recruitment in Chronic Inflammation Induced by Hydrocarbon Oil , 2011, The Journal of Immunology.

[29]  F. Zhang,et al.  Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China , 2010, Lupus.

[30]  S. Nagata,et al.  Autoimmunity and the Clearance of Dead Cells , 2010, Cell.

[31]  L. de Leval,et al.  Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. , 2009, The Journal of clinical investigation.

[32]  Steven L. Kunkel,et al.  Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[33]  M. Satoh,et al.  Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. , 2009, Trends in immunology.

[34]  Yi Li,et al.  Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. , 2009, The American journal of pathology.

[35]  D. Yuan.  Faculty Opinions recommendation of TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. , 2009 .

[36]  S. Akira,et al.  TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus , 2008, The Journal of experimental medicine.

[37]  M. Carroll,et al.  Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. , 2008, Molecular immunology.

[38]  L. Moldawer,et al.  A Novel Type I IFN-Producing Cell Subset in Murine Lupus1 , 2008, The Journal of Immunology.

[39]  Michael D. Connolly,et al.  Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.

[40]  Kindra M Kelly-Scumpia,et al.  Deficiency of the type I interferon receptor protects mice from experimental lupus. , 2007, Arthritis and rheumatism.

[41]  J. Whittle,et al.  Not Your Typical Pneumonia: A Case of Exogenous Lipoid Pneumonia , 2007, Journal of General Internal Medicine.

[42]  J. Grande,et al.  Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. , 2007, Rheumatology.

[43]  S. Akira,et al.  Identification of a key pathway required for the sterile inflammatory response triggered by dying cells , 2007, Nature Medicine.

[44]  R. Hamilton,et al.  MARCO Mediates Silica Uptake and Toxicity in Alveolar Macrophages from C57BL/6 Mice* , 2006, Journal of Biological Chemistry.

[45]  T. Mayadas,et al.  Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy. , 2006, Immunity.

[46]  F. Silvestris,et al.  Induction of Apoptosis by the Hydrocarbon Oil Pristane: Implications for Pristane-Induced Lupus1 , 2005, The Journal of Immunology.

[47]  R. Voll,et al.  Impaired clearance of dying cells in systemic lupus erythematosus. , 2005, Autoimmunity reviews.

[48]  H. Hechtman,et al.  Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Cohen,et al.  Inhibition of IL-10 Receptor Function in Alveolar Macrophages by Toll-Like Receptor Agonists1 , 2004, The Journal of Immunology.

[50]  Edward Abraham,et al.  Neutrophils and acute lung injury , 2003, Critical care medicine.

[51]  T. Franks,et al.  Pulmonary capillaritis , 2000, Current opinion in pulmonary medicine.

[52]  M. Satoh,et al.  Fas and Fas Ligand Mutations Inhibit Autoantibody Production in Pristane-Induced Lupus1 , 2000, The Journal of Immunology.

[53]  R. Matthay,et al.  Pulmonary manifestations of systemic lupus erythematosus. , 1998, Clinics in chest medicine.

[54]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[55]  M. Zamora,et al.  Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome , 1997, Medicine.

[56]  L. Kobzik,et al.  Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. , 1996, Journal of immunology.

[57]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[58]  M. Ishii,et al.  Immunopathologic studies of pneumonitis in systemic lupus erythematosus. , 1979, Annals of internal medicine.

[59]  T. Kuiken,et al.  Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.

[60]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[61]  D. Ricklin,et al.  Compstatin: a complement inhibitor on its way to clinical application. , 2008, Advances in experimental medicine and biology.

[62]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[63]  T. Takahashi.  [Erythematosus]. , 1971, Nihon rinsho. Japanese journal of clinical medicine.